NDC 60505-7085-0 - FENTANYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-7085
- Requested NDC
- 60505-7085-0
- Package NDCs from labels
- 60505-7085-0, 60505-7085-2
- Manufacturer
- Apotex Corp.
- Effective date
- 2023-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FENTANYL - Apotex Corp. | Apotex Corp. | 2023-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-7085 | FENTANYL PATCH, EXTENDED RELEASE [APOTEX CORP.] | 8 | Legacy NDC | 20230502_0ff70df0-2cda-d96c-42a8-3bf180310499.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-7085-0 | EA - Each | 60505-7085 | eda0ece9-6104-4c1e-94b2-96de0f720afb | 1 | 2018-04-19 |
| 60505-7085-2 | EA - Each | 60505-7085 | aac5f622-7287-4794-aed6-66ea641653df | 1 | 2018-04-19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FENTANYL TRANSDERMAL | FENTANYL TRANSDERMAL | SpecGx LLC | e15a7e9b-8025-49dd-9a6d-bafcccf1959f | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | UF599785JZ |
| FENTANYL | FENTANYL | Aveva Drug Delivery Systems Inc. | 73897c38-e4ec-40bc-9f41-3359ee23a5a8 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | ANDA077449 UF599785JZ |
| FENTANYL | FENTANYL | INGENUS PHARMACEUTICALS, LLC | bf02ffd0-cc5d-446b-b648-378f6885052f | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | ANDA077449 UF599785JZ |
| Fentanyl system | FENTANYL | ALVOGEN | 242759ef-cb6d-4e3e-9f8d-5e31efa1f289 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | UF599785JZ |
| FENTANYL | FENTANYL | Mylan Pharmaceuticals Inc. | 2a2238e9-4b5d-c56d-8663-dd354ff9ae0c | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | UF599785JZ |
| 6319f139-d677-f101-0a24-28aa1c03f316 | 0ff70df0-2cda-d96c-42a8-3bf180310499 | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | 6319f139-d677-f101-0a24-28aa1c03f316 0ff70df0-2cda-d96c-42a8-3bf180310499 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.